Skip to main content
Clinical Trials/CTRI/2010/091/000197
CTRI/2010/091/000197
Completed
Phase 1

Evaluation of efficacy and anti-inflammatory action of PlacentrexTM in women with inflammatory Pap smears

ALBERT DAVID LTD KOLKATA0 sites150 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
ALBERT DAVID LTD KOLKATA
Enrollment
150
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ALBERT DAVID LTD KOLKATA

Eligibility Criteria

Inclusion Criteria

  • PAP SMEAR SHOWING INFLAMMATION
  • ABILITY TO GIVE INFORMED CONSENT
  • SEXUALLY ACTIVE
  • NO DEBILITATING DISEASE

Exclusion Criteria

  • OBVIOUS GROWTH
  • PREVIOUS PROCEDURES, EG. EXCISION BIOPSY,CRYOTHERAPY AND CONISATION AND HYSTERECTOMY
  • ACUTE CERVICITIS AND VAGINITIS
  • SEVERE DEBILITATING DISEASE

Outcomes

Primary Outcomes

Not specified

Similar Trials